Form 4: DocuSign Executive Daniel Springer Sells Shares and Exercises Options
SEC Form 4 Filing
DocuSign executive Daniel Springer executed multiple transactions involving the company's stock, including sales and option exercises, on December 10, 2024.
Summary
- On December 10, 2024, Daniel Springer, an executive at DocuSign, engaged in several transactions involving the company's common stock.
- These transactions included the acquisition of 592,686 shares through the exercise of stock options at a price of $18.02 per share.
- Springer also sold a total of 515,200 shares of common stock at prices ranging from $95.26 to $101.02 per share.
- The sales were executed in multiple tranches, with prices varying slightly across each tranche.
- The shares are held by The Daniel Springer Revocable Trust, of which Springer is the trustee.
- The stock options were granted with a vesting schedule that began on January 11, 2018, with 25% vesting immediately and the remainder vesting monthly over 36 months.
Sentiment
Score: 5
Explanation: The document reflects standard executive stock transactions. While the sales could be seen as slightly negative, the option exercise is a positive sign. Overall, the sentiment is neutral.
Positives
- The exercise of stock options indicates a potential belief in the company's long-term value by the executive.
- The sales of shares at prices significantly higher than the option exercise price resulted in a substantial profit for the executive.
Negatives
- The sale of a large number of shares by an executive could be interpreted negatively by the market, potentially signaling a lack of confidence in the company's short-term prospects.
Risks
- Large sales by insiders can sometimes lead to downward pressure on the stock price.
- The market may react negatively to the perception of an executive reducing their stake in the company.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are closely monitored by investors for insights into management's perspective on the company's future.
Comparison to Industry Standards
- Executive stock transactions are a normal part of compensation for publicly traded companies.
- The size of the transaction is not unusual for an executive of a company the size of DocuSign.
- The vesting schedule of the options is typical for stock-based compensation.
Stakeholder Impact
- Shareholders may react to the news of the executive's stock sales, potentially impacting the stock price.
- Employees may view the executive's actions as a sign of confidence or lack thereof in the company's future.
Key Dates
| Date | Description |
|---|---|
| 2018-01-11 | Initial vesting date for 25% of the stock options. |
| 2024-12-10 | Date of stock option exercise and share sales. |
| 2024-12-11 | Date of filing of the transaction. |
| 2027-01-22 | Expiration date of the stock options. |
Keywords
DocuSign, stock options, insider trading, share sales, executive transactions, Daniel Springer, common stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.